Is Ustekinumab Effective in Refractory Crohn's Disease of the Pouch and Chronic Pouchitis? A Systematic Review.

Digestive Diseases and Sciences
Chiara RocchiDario Sorrentino

Abstract

Crohn's disease (CD) of the pouch and chronic pouchitis represent the most common long-term complications of total proctocolectomy and ileal pouch anal anastomosis (IPAA) for refractory ulcerative colitis (UC). These conditions are treated with multiple agents, including antibiotics, immunomodulators, and biologics. Among the latter, ustekinumab is approved for both CD and UC. We performed a systematic review to evaluate the efficacy of this anti-IL12/23 in CD of the pouch and chronic refractory pouchitis. Pubmed, Embase, Ovid, and the Cochrane Controlled Trials Register were searched to identify studies published until August 2020 investigating the use of ustekinumab for these conditions. Eighty-six eligible patients with IPAA-51 with CD of the pouch, 35 with chronic pouchitis-were identified from 2 retrospective studies and 5 case reports. Reported clinical response to ustekinumab was 63 and 85% in chronic pouchitis and CD of the pouch after 4-12 and 4-16 weeks, respectively. Clinical remission was reported in 10% of patients with chronic pouchitis and 27% of patients with CD of the pouch after 8-52 and 4-52 weeks of treatment, respectively. Endoscopic response was reported in 60% and 67% of patients with chronic pouchitis an...Continue Reading

References

Jul 8, 1978·British Medical Journal·A G Parks, R J Nicholls
Nov 27, 2001·Inflammatory Bowel Diseases·B ShenV W Fazio
Jun 20, 2002·Diseases of the Colon and Rectum·Udo A HeuschenGundi Heuschen
Dec 17, 2009·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·A L GrucelaD B Chessin
Apr 4, 2012·Diseases of the Colon and Rectum·Hideyuki SuzukiIwao Sasaki
Aug 10, 2012·International Journal of Colorectal Disease·Manabu Shiraki, Takayuki Yamamoto
May 31, 2014·Clinical and Experimental Gastroenterology·Renata D'Incà, Roberta Caccaro
Oct 4, 2014·World Journal of Gastroenterology : WJG·Samuel D JamesChanjuan Shi
Aug 14, 2015·World Journal of Gastroenterology : WJG·Petros Zezos, Fred Saibil
Apr 9, 2016·Inflammatory Bowel Diseases·Amy L LightnerEdward J Loftus
Dec 14, 2016·The New England Journal of Medicine·Brian G FeaganUNKNOWN UNITI–IM-UNITI Study Group
Feb 16, 2017·Journal of Crohn's & Colitis·My-Linh Tran-MinhJean-Marc Gornet
Mar 1, 2017·Alimentary Pharmacology & Therapeutics·D Q HoltM A Kamm
Jan 6, 2018·International Journal of Colorectal Disease·Anders Mark-ChristensenSøren Laurberg
Feb 1, 2018·Journal of Crohn's & Colitis·Emily K WrightWilliam R Connell
Feb 10, 2018·Techniques in Coloproctology·N Teich, A Stallmach
Apr 17, 2018·Journal of Crohn's & Colitis·Jack PeterAndreas Stallmach
Apr 19, 2018·Inflammatory Bowel Diseases·Amandeep SinghBo Shen
Apr 25, 2018·Inflammatory Bowel Diseases·Freeha Khan, Bo Shen
Aug 1, 2018·Best Practice & Research. Clinical Gastroenterology·Gaetano GalloAntonino Spinelli
Oct 9, 2018·Inflammatory Bowel Diseases·Kimberly N WeaverEdward L Barnes
Apr 13, 2019·Gastroenterology Report·Amandeep SinghJessica Philpott
Jun 13, 2019·Digestive Diseases and Sciences·Jacob E OllechSushila R Dalal
Sep 26, 2019·The New England Journal of Medicine·Bruce E SandsUNKNOWN UNIFI Study Group
Oct 4, 2019·Alimentary Pharmacology & Therapeutics·Maia KayalRyan C Ungaro
Jan 9, 2020·World Journal of Gastrointestinal Pathophysiology·Marrieth G RubioDario Sorrentino
Mar 7, 2020·Frontline Gastroenterology·Richard James HarrisJ R Fraser Cummings
Mar 17, 2020·Digestion·Michael Christian SulzUNKNOWN on behalf of the Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.